178 related articles for article (PubMed ID: 9722988)
1. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Pettitt AR
Br J Haematol; 2003 Jun; 121(5):692-702. PubMed ID: 12780783
[No Abstract] [Full Text] [Related]
3. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
[TBL] [Abstract][Full Text] [Related]
5. Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
Wilson PK; Mulligan SP; Christopherson RI
Leuk Res; 2004 Jul; 28(7):725-31. PubMed ID: 15158094
[TBL] [Abstract][Full Text] [Related]
6. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
7. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
8. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Niitsu N; Umeda M; Honma Y
Leuk Res; 2000 Jan; 24(1):1-9. PubMed ID: 10634639
[TBL] [Abstract][Full Text] [Related]
9. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
Mactier S; Henrich S; Che Y; Kohnke PL; Christopherson RI
J Proteome Res; 2011 Mar; 10(3):1030-42. PubMed ID: 21182289
[TBL] [Abstract][Full Text] [Related]
12. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
Korycka A; Robak T
Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
[TBL] [Abstract][Full Text] [Related]
13. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
Zinzani PL; Tosi P; Visani G; Martinelli G; Farabegoli P; Buzzi M; Ottaviani E; Salvucci M; Bendandi M; Zaccaria A
Am J Hematol; 1994 Dec; 47(4):301-6. PubMed ID: 7977303
[TBL] [Abstract][Full Text] [Related]
15. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
16. New prospects in the treatment of indolent lymphomas with purine analogues.
Cheson BD
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
[TBL] [Abstract][Full Text] [Related]
17. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
18. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
[TBL] [Abstract][Full Text] [Related]
19. High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.
Löfgren C; Albertioni F; Paul C
Ther Drug Monit; 2005 Oct; 27(5):641-6. PubMed ID: 16175139
[TBL] [Abstract][Full Text] [Related]
20. Potential immunological action of purine nucleoside analogues.
Dighiero G
Drugs; 1994; 47 Suppl 6():57-62. PubMed ID: 7525190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
